ADORA2A and neoplasm: Upon conversion of AMP to adenosine by CD73 in tumor cells, adenosine mediates its immunosuppressive effect by binding to adenosine receptors, A2A receptor (A2AR) and A2B receptor (A2BR) on immune cells.